References
- Suffredini AF, Fantuzzi G, Badolato R, Oppenheim JJ, O'Grady NP (1999). New insights into the biology of the acute phase response. J Clin Immunol 19: 203–14.
- Hedlund P (1947). The appearance of acute phase protein in various diseases. Acta Med Scand 124: 579–82.
- Mc Conkey B, Crockson RA, Crockson AP (1972). The assessment of rheumatoid arthritis: A study based on measurements of the serum acute-phase reactants. Quart J Med 16: 115–25.
- Clyne B, Olshaker JS (1999). The C-reactive protein. J Emerg Med 17: 1019–25.
- Du Clos TW (2000). Function of C-reactive protein. Ann Med 32: 274–8.
- Fähreus R (1921). The suspension-stability of the blood. Acta Med Scand 55: 1–228.
- Kavanaugh A (1999). The role of the laboratory in the evaluation of rheumatic diseases. Clin Cor-nerstone 2: 11–25.
- Wollheim FA (2000). Markers of disease in rheumatoid arthritis. Curr Opin Rheumatol 12: 200–05.
- Sheam MA, Kang IY (1986). Effect of age and sex on the erythrocyte sedimentation rate . J Rheumatol 13: 297–302.
- Brigden M (1998). The erythrocyte sedimentation rate. Still a helpful test when used judiciously. Postgrad Med 103: 257–62.
- Zlonis M (1993). The mystique of the erythrocyte sedimentation rate. A reappraisal of one of the oldest laboratory tests still in use. Clinics Lab Med 13: 787–96.
- Crockson RA, Crockson AP (1974). Relationship of the erythrocyte sedimentation rate to viscosi-ty and plasma proteins in rheumatoid arthritis. Ann Rheum Dis 33: 53–6.
- Sox HC, Liang MH (1986). The erythrocyte sedimentation rate. Guidelines for rational use. Annals Intern Med 104: 515–23.
- Brigden ML (1999). Clinical utility of the erythrocyte sedimentation rate. Am Fam Physician 60: 1443–50.
- Hansson LO, Carlsson I, Hansson E, Hovelius B, Svensson P. Tryding N (1995). Measurement of C-reactive protein and the erythrocyte sedimentation rate in general practice. Scand J Prim Health Care 13: 39–45.
- Richardson C, Emery P (1996). Laboratory markers of disease activity. J Rheumatol 23: 23–30.
- Wolfe F (1997). Comparative usefulness of C-reactive protein and erythrocyte sedimentation rate in patients with rheumatoid arthritis. J Rheumatol 24: 1477–85.
- Stuart J, Whicher JT (1988). Tests for detecting and monitoring the acute phase response. Arch Dis Child 63: 115–17.
- Blackburn WD (1994). Validity of acute phase proteins as markers of disease activity. J Rheuma-tol 42: 9–13.
- Arvidson NG, Gudbjörnsson B, Hällgren R, Larsson, A (1998). Concordant message of different inflammation markers in patients with rheumatoid arthritis. Upsala J Med Sci 103: 35–42.
- Arvidson NG, Larsson A, Larsen A (2002). Disease activity in rheumatoid arthritis: fibrinogen is superior to the erythrocyte sedimentation rate. Scand J Chin Lab Invest 62: 315–9.
- Larsen A (1988). The relation of radiographic changes to serum acute-phase proteins and rheuma-toid factor in 200 patients with rheumatoid arthritis. Scand J Rheumatol 17: 123–9.
- Sjoblom KG, Saxne T, Pettersson H, Wollheim FA (1984). Factors related to the progression of joint destruction in rheumatoid arthritis. Scand J Rheumatology 13: 21–27.
- Thue G, Sandberg S, Fugelli P (1994). The erythrocyte sedimentation rate in general practice: clinical assessment based on case histories. Scand J Chin Lab Invest 54: 291–300.Corresponding author: Anders Larsson